TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
Market News Page 100 of 162 • 4,033 articles
CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • Rosen Law Firm
CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

11/05/2025 06:50 PM • Rosen Law Firm is investigating potential securities claims for Car-Mart shareholders after the company reported a significant first-quarter loss and stock price drop of 18.2%.

CRMT - Company reported a first-quarter loss of 69 cents per share (compared to 15 cents loss in previous year), resulting in an 18.2% stock price decline on September 4, 2025
#securities claims #investor losses #stock performance
Read More
Virtual Power Plant Market Projected to Reach $5.5 Billion, at a 23.4% CAGR by 2029 | MarketsandMarkets™
GlobeNewswire Inc. • Marketsandmarkets™
Virtual Power Plant Market Projected to Reach $5.5 Billion, at a 23.4% CAGR by 2029 | MarketsandMarkets™

11/05/2025 06:30 PM • The global Virtual Power Plant Market is expected to grow from $1.9 billion in 2024 to $5.5 billion by 2029, with a 23.4% CAGR, driven by renewable energy integration, grid stability, and decarbonization efforts.

SIEGY - Mentioned as a key market player in the growing virtual power plant market with strong potential for expansion
#virtual power plant #renewable energy #grid stability #decarbonization #distributed energy
Read More
Portnoy Law Firm Announces Class Action on Behalf of CarMax, Inc. Investors
GlobeNewswire Inc. • Lesley F. Portnoy
Portnoy Law Firm Announces Class Action on Behalf of CarMax, Inc. Investors

11/05/2025 06:30 PM • CarMax faces potential class action lawsuit after reporting significant sales declines in Q2 fiscal year 2026, with stock price dropping 20% following disappointing financial results attributed to tariff-related demand shifts.

ORCL - Partnering in a landmark collaboration to deliver high-performance AI capabilities for national scientific research
KMX - Company experienced substantial retail and wholesale sales declines, reduced net income by 28%, and saw significant stock price drop after reporting disappointing quarterly financial results
#class action #used car sales #tariffs #financial performance
Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)
GlobeNewswire Inc. • Brodsky & Smith
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)

11/05/2025 06:27 PM • Law firm Brodsky & Smith is investigating potential breaches of fiduciary duties by boards of several companies during merger and acquisition processes, focusing on whether shareholders are receiving fair value.

CSCO - Accelerating secure network connectivity and contributing core network software for the AI-native wireless stack
KVUE - Being acquired by Kimberly-Clark at $21.01 per share, but investigation suggests potential concerns about fairness of the deal
#mergers #acquisitions #shareholder investigations #fiduciary duties
Read More
Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property
GlobeNewswire Inc. • Nicholas Luksha
Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property

11/05/2025 06:27 PM • Mustang Energy conducted a high-resolution HTDEM survey at the 914W Uranium Project, covering 136 line-kilometers. The survey revealed a conductive zone potentially favorable for uranium mineralization, with soil sampling identifying some anomalous uranium values in the northeastern portion of the project area.

BAH - Developed advanced AI-powered spectrum sensing application and collaborated on multimodal sensing technology
CCJ - Referenced only in context of nearby operations, with no direct involvement in the current project
#uranium #HTDEM survey #exploration #geophysical survey #soil sampling
Read More
Nextdoor (NXDR) Q3 2025 Earnings Call Transcript
The Motley Fool • Motley Fool Transcribing
Nextdoor (NXDR) Q3 2025 Earnings Call Transcript

11/05/2025 06:18 PM • Nextdoor reported record quarterly revenue of $69 million in Q3 2025, with 33% growth in self-serve advertising revenue. The company is focusing on improving user experience, content quality, and platform engagement while maintaining disciplined cost management.

TMUS - Mentioned as a partner without specific details of direct contribution
NXDR - Achieved highest quarterly revenue, positive adjusted EBITDA, strong self-serve advertising growth, strategic content and product enhancements, and clear long-term growth strategy
#earnings #advertising #platform #user engagement #revenue growth
Read More
GBank Financial Holdings Inc. Announces Resignation of Founding Director Alan C. Sklar from its Board of Directors
GlobeNewswire Inc. • Edward M. Nigro
GBank Financial Holdings Inc. Announces Resignation of Founding Director Alan C. Sklar from its Board of Directors

11/05/2025 06:15 PM • Alan C. Sklar, a founding director of GBank, has resigned from the Board of Directors after nearly two decades of service, citing increased law firm commitments and a desire to spend more time in Israel.

TMUSI - Mentioned as a partner without specific details of direct contribution
GBFH - The resignation appears planned and amicable, with the CEO expressing gratitude for Sklar's long-standing contributions, suggesting a smooth leadership transition
#resignation #board of directors #founding director #leadership transition
Read More
2 Reasons I'm Keeping My Eye on Eli Lilly Stock Right Now
The Motley Fool • Manali Pradhan
2 Reasons I'm Keeping My Eye on Eli Lilly Stock Right Now

11/05/2025 06:09 PM • Eli Lilly reported strong Q3 performance with 54% revenue growth and impressive diabetes/weight loss drug market share. The company is expanding its GLP-1 drug portfolio and has promising pipeline developments in multiple therapeutic areas.

TMUSL - Mentioned as a partner without specific details of direct contribution
LLY - Strong financial performance, dominant market share in incretin analog market, promising drug pipeline with potential FDA approvals for oral GLP-1 drugs, and expansion in multiple therapeutic areas including oncology, neuroscience, and immunology
#pharmaceuticals #GLP-1 drugs #diabetes #weight loss #healthcare #drug development
Read More
Minerva Foods' free cash flow reaches R$2.5 billion in the third quarter of 2025.
Benzinga • Prnewswire
Minerva Foods' free cash flow reaches R$2.5 billion in the third quarter of 2025.

11/05/2025 06:03 PM • Minerva Foods reported record financial performance in Q3 2025, with free cash flow of R$2.5 billion, net revenue of R$15.5 billion, and reduced leverage to 2.5x, marking its strongest quarterly results since 2018.

TMUSZ - Mentioned as a partner without specific details of direct contribution
MRVSY - Strong financial performance with record free cash flow, net revenue growth of 82.5% year-over-year, reduced leverage, and successful integration of new assets
#free cash flow #financial results #beef exports #revenue growth #leverage reduction
Read More
Camping World Holdings, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (CWH)
GlobeNewswire Inc. • Kirby Mcinerney Llp
Camping World Holdings, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (CWH)

11/05/2025 06:00 PM • Camping World Holdings announced financial misstatements related to deferred tax assets, causing a 24.79% stock price decline after revising its 2024 annual report.

BEAT - Emerges as first cable-free 12-lead ECG, potentially replicating diagnostic gold standard
CWH - Stock price dropped significantly after revealing accounting discrepancies in deferred tax assets, suggesting potential financial reporting issues and triggering a legal investigation
#securities fraud #financial misstatement #tax assets #stock price decline
Read More
DXCM: Kirby McInerney LLP Advises DexCom, Inc. Investors of Class Action Lawsuit
GlobeNewswire Inc. • Kirby Mcinerney Llp
DXCM: Kirby McInerney LLP Advises DexCom, Inc. Investors of Class Action Lawsuit

11/05/2025 06:00 PM • A securities fraud lawsuit alleges DexCom made unauthorized design changes to its G6 and G7 glucose monitors, rendering them less reliable and posing health risks to users, which led to significant stock price declines and potential regulatory scrutiny.

GOOGL - Contributes to consumer wearables market with heart monitoring features
DXCM - Multiple negative events including FDA warning letter, research firm downgrade, and a report revealing serious device performance issues and potential patient harm, resulting in significant stock price drops and potential regulatory and legal risks
#securities fraud #glucose monitors #FDA warning #medical device #stock decline
Read More
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights – MLTX
GlobeNewswire Inc. • The Gross Law Firm
MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights – MLTX

11/05/2025 06:00 PM • A securities fraud class action lawsuit has been filed against MoonLake Immunotherapeutics, alleging the company made false or misleading statements about its drug candidate SLK's clinical benefits and efficacy.

GOOG - Contributes to consumer wearables market with heart monitoring features
MLTX - The lawsuit alleges the company misrepresented its drug candidate's potential, suggesting potential intentional deception about SLK's clinical advantages and molecular structure
#securities fraud #class action lawsuit #drug development #nanobody #clinical trials
Read More
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit – BAX
GlobeNewswire Inc. • The Gross Law Firm
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit – BAX

11/05/2025 06:00 PM • The Gross Law Firm has issued a notice to Baxter International shareholders regarding a potential securities class action lawsuit alleging product defects with the Novum LVP medical device that caused patient risks and potential safety issues.

BAX - The lawsuit alleges serious product defects with the Novum LVP medical device, including potential patient injuries and deaths, systemic malfunctions, and misleading statements about product safety and performance
#securities lawsuit #medical device #product defects #shareholder notice
Read More
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Fly-E Group, Inc.(FLYE) Shareholders
GlobeNewswire Inc. • The Gross Law Firm
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Fly-E Group, Inc.(FLYE) Shareholders

11/05/2025 05:59 PM • The Gross Law Firm announced a securities class action lawsuit against Fly-E Group for allegedly making false statements about lithium battery safety and E-vehicle sales, resulting in a dramatic 87% stock price decline.

FLYE - Stock price dropped 87% after revealing decreased revenues, battery safety concerns, and inability to file quarterly financial report, indicating significant corporate and operational challenges
#securities lawsuit #lithium battery #E-vehicle #stock decline #class action
Read More
The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – ATYR
GlobeNewswire Inc. • The Gross Law Firm
The Gross Law Firm Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – ATYR

11/05/2025 05:59 PM • aTyr Pharma faces a class action lawsuit after announcing disappointing clinical trial results for Efzofitimod, which failed to meet its primary endpoint, causing an 83.2% stock price decline.

PHG - Traditional device maker being challenged by emerging innovators
ATYR - Stock price dropped 83.2% after revealing clinical trial failure for Efzofitimod, indicating significant investor disappointment and potential legal challenges
#class action #securities lawsuit #clinical trial #pharmaceutical #stock decline
Read More
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 20, 2025 in RCI Hospitality Holdings, Inc. Lawsuit – RICK
GlobeNewswire Inc. • The Gross Law Firm
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 20, 2025 in RCI Hospitality Holdings, Inc. Lawsuit – RICK

11/05/2025 05:59 PM • The Gross Law Firm has issued a notice to shareholders of RCI Hospitality Holdings regarding a potential securities class action lawsuit alleging tax fraud, bribery, and misleading statements during the period of December 15, 2021 to September 16, 2025.

BEATW - Emerges as first cable-free 12-lead ECG, potentially replicating diagnostic gold standard
RICK - The lawsuit alleges serious misconduct including tax fraud, bribery, and issuing false/misleading statements about the company's business, operations, and legal risks
#securities lawsuit #class action #tax fraud #shareholder notice
Read More
Marex Group plc Sued for Securities Law Violations - Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights – MRX
GlobeNewswire Inc. • The Gross Law Firm
Marex Group plc Sued for Securities Law Violations - Contact The Gross Law Firm Before December 8, 2025 to Discuss Your Rights – MRX

11/05/2025 05:58 PM • The Gross Law Firm has filed a securities lawsuit against Marex Group, alleging the company improperly inflated financial metrics through off-book intercompany transactions during the period of May 16, 2024 to August 5, 2025.

MRX - Accused of fraudulent financial reporting by improperly inflating cash flow, revenues, assets, and profits through undisclosed intercompany transactions, which suggests potential serious corporate misconduct
#securities lawsuit #financial misconduct #class action #investor rights
Read More
Fortinet, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before November 21, 2025 to Discuss Your Rights – FTNT
GlobeNewswire Inc. • The Gross Law Firm
Fortinet, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before November 21, 2025 to Discuss Your Rights – FTNT

11/05/2025 05:57 PM • Fortinet faces a securities fraud class action lawsuit alleging false statements about product refresh cycle and firewall upgrade potential during November 2024 to August 2025 period.

LCID - Advancing level 4 autonomous capabilities for next-generation vehicles using NVIDIA's technology
FTNT - Accused of making false statements about product refresh cycle, misrepresenting firewall upgrade potential, and potentially misleading investors about business performance
#securities fraud #class action #shareholder lawsuit #stock misrepresentation
Read More
Duolingo Stock Dives On Q3 Earnings: What You Need To Know
Benzinga • Adam Eckert
Duolingo Stock Dives On Q3 Earnings: What You Need To Know

11/05/2025 05:44 PM • Duolingo reported strong Q3 earnings with revenue of $271.7 million and 36% year-over-year user growth, but stock dropped due to slower sequential user growth and market reaction.

UBER - Scaling global autonomous fleet to 100,000 vehicles and developing unified ride-hailing network with NVIDIA
DUOL - Despite beating revenue estimates and increasing user base, stock price dropped 17.34% due to slower sequential user growth and market perception of reduced growth momentum
#earnings #language learning #user growth #revenue #social media marketing
Read More
Oracle Stock Near $250 as OpenAI Partnership Redefines Cloud Growth Trajectory
Investing.com • Itai Smidt
Oracle Stock Near $250 as OpenAI Partnership Redefines Cloud Growth Trajectory

11/05/2025 05:24 PM • Oracle is experiencing significant growth through its AI infrastructure partnership with OpenAI, expanding cloud services, and strategic multi-cloud deployment. The company raised substantial capital to build AI data centers and is positioning itself as a key player in global AI compute infrastructure.

NVDA - Leading autonomous driving technology development and expanding ecosystem with multiple strategic partnerships
ORCL - Strong revenue growth (12.17% YoY), massive $300 billion OpenAI partnership, 77% cloud infrastructure growth forecast, expanding market share from 1% to 2.7%, and projected fair value of $327 per share
#AI #cloud computing #OpenAI #infrastructure #multi-cloud #enterprise software
Read More
Why Apollo Global Is Soaring This Week
The Motley Fool • Matthew Benjamin
Why Apollo Global Is Soaring This Week

11/05/2025 05:20 PM • Apollo Global Management reported strong Q3 results, with fee-related earnings up 23% and adjusted net income exceeding Wall Street estimates. The company's assets under management are approaching $1 trillion, driven by significant capital inflows and strong performance from its Athene insurance unit.

MBGYY - Testing future collaboration and developing autonomous capabilities with proprietary MB.OS and NVIDIA platform
APO - Exceeded quarterly earnings estimates, increased fee-related earnings by 23%, achieved $82 billion in capital inflows, and nearing $1 trillion in assets under management
#asset management #quarterly earnings #insurance #investment #capital inflows
Read More
Why Champion Homes Stock Triumphed Today
The Motley Fool • Eric Volkman
Why Champion Homes Stock Triumphed Today

11/05/2025 05:17 PM • Champion Homes reported strong Q2 2026 earnings, with net sales increasing 11% year-over-year to $684 million and beating analyst expectations, driving the stock price up by nearly 14%.

SKY - Company exceeded analyst estimates with 11% net sales growth, 3% increase in total home sales, and 7% rise in average selling price, leading to a significant stock price increase
#mobile homes #factory-produced housing #earnings report #Q2 2026
Read More
AMH Announces Distributions
Benzinga • Prnewswire
AMH Announces Distributions

11/05/2025 05:16 PM • American Homes 4 Rent (AMH) announced quarterly dividend distributions of $0.30 per common share and specific distributions for preferred shares, payable on December 31, 2025 to shareholders of record on December 15, 2025.

CMG - More affluent trade areas offering greater pricing flexibility and steadier spending patterns, with more stable consumer base
AMH - Company announced consistent dividend payments, highlighted recent achievements like being named a Great Place to Work and Top U.S. Homebuilder, and reported owning over 61,000 single-family properties across multiple U.S. regions
#dividend #real estate #REIT #single-family rental #distribution
Read More
Spotify Posts Huge EPS Beat: Shares Are Still Down Big From Highs
Investing.com • Leo Miller
Spotify Posts Huge EPS Beat: Shares Are Still Down Big From Highs

11/05/2025 05:15 PM • Spotify reported strong Q3 2025 earnings with a significant EPS beat, though the performance was partially due to accounting adjustments. The company is transitioning leadership with new co-CEOs taking over from founder Daniel Ek in January 2026.

SPOT - Mixed performance with strong EPS beat but accounting-driven improvements, cautious investor reaction to leadership change, and modest revenue growth
#music streaming #earnings #CEO transition #ad-supported tier
Read More
Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look
The Motley Fool • Josh Kohn-Lindquist
Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look

11/05/2025 05:12 PM • Renaissance Group initiated a new $35.11 million position in Halozyme Therapeutics, acquiring 478,735 shares representing 1.32% of its U.S. equity assets. The biotech company offers innovative drug delivery technology and has demonstrated strong financial performance with consistent sales growth.

ESAIY - Collaborative partner in successful cancer therapy trial
HALO - Strong financial metrics including 38% annual sales growth over the last decade, 47% net income margin, successful licensing model, and consistent stock performance outpacing S&P 500
#biotech #drug delivery #investment #Renaissance Group #ENHANZE technology
Read More